Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01237236
Title A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

lymphoma

Advanced Solid Tumor

Therapies

Ribociclib

Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.